Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001493152-25-029353

Chief Operating Officer acquired 54,421 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Linscott Walt Addison · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-22 Grant or award : show line 1 in the form +54,421 $2.03 $110,475 54,426 D
Loading xslF345X05/ownership.xml…